JG
XERS icon

Joel Greenblatt’s Xeris Biopharma Holdings XERS Stock Holding History

Joel Greenblatt’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$981K Buy
123,914
+80,657
+186% +$515K ﹤0.01% 1364
2026
Q1 		$251K Buy
43,257
+7,845
+22% +$52K ﹤0.01% 1638
2025
Q4 		$278K Sell
35,412
-7,329
-17% -$57.7K ﹤0.01% 1586
2025
Q3 		$348K Buy
42,741
+9,975
+30% +$66.3K ﹤0.01% 1479
2025
Q2 		$153K Buy
32,766
+16,534
+102% +$75.8K ﹤0.01% 1596
2025
Q1 		$89.1K Buy
+16,232
New +$65.5K ﹤0.01% 1512

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Joel Greenblatt's XERS Position: Q2 2026 in Review

Joel Greenblatt increased its Xeris Biopharma Holdings (XERS) stake by 186% in Q2 2026, buying an estimated $515K and bringing the position to 123,914 shares worth $981K. The position accounts for ﹤0.01% of the portfolio, ranked #1364.

Joel Greenblatt first reported a position in XERS in Q1 2025 and has held it in 6 quarters since. 237 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Joel Greenblatt held 123,914 shares of Xeris Biopharma Holdings worth $981K as of Q2 2026.
  • Joel Greenblatt bought 80,657 Xeris Biopharma Holdings shares in Q2 2026, an estimated $515K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1364 holding.
  • Joel Greenblatt first reported a position in Xeris Biopharma Holdings in Q1 2025 and has held it in 6 quarters since.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.